Praxis Precision Medicines (PRAX) Research & Development (2019 - 2026)
Praxis Precision Medicines (PRAX) posted Research & Development of $69.4 million for Q2 2026, down 10.99% on a QoQ basis from $78.0 million in Q1 2026, and up 10.17% year-over-year from $63.0 million in Q2 2025.
Powered by 
Analysis
Praxis Precision Medicines (PRAX) Research & Development (2019 - 2026) Analysis & Trends
Praxis Precision Medicines has reported Research & Development for 8 years, with the latest figure at $69.4 million in Q2 2026.
- On a quarterly basis, Research & Development rose 10.17% year-over-year to $69.4 million in Q2 2026; TTM through Jun 2026 was $290.7 million, a 30.96% increase from a year earlier, with the FY2025 full-year figure at $267.1 million, up 75.26% from the prior year.
- Research & Development was $69.4 million for Q2 2026 at Praxis Precision Medicines, down from $78.0 million in the prior quarter.
- The five-year high for Research & Development was $78.0 million in Q1 2026, with the low at $17.3 million in Q3 2023.
- Average Research & Development over 5 years is $44.9 million, with a median of $42.8 million recorded in 2022.
- The sharpest annual moves came in 2023 and 2024: Research & Development tumbled 51.56% in 2023, then surged 206.11% in 2024.
- Over 5 years, Research & Development stood at $28.3 million in 2022, then plunged by 35.09% to $18.4 million in 2023, then soared by 206.11% to $56.3 million in 2024, then soared by 37.7% to $77.5 million in 2025, then decreased by 10.44% to $69.4 million in 2026.
- The last three Research & Development figures came in at $69.4 million (Q2 2026), $78.0 million (Q1 2026), and $77.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.54 Bn | 198.55 Bn | 7.24 Bn | 1.87 Bn |
| 2 | Gilead Sciences | 186.84 Bn | 183.58 Bn | 6.22 Bn | 1.76 Bn |
| 3 | Vertex Pharmaceuticals | 129.39 Bn | 121.54 Bn | 2.84 Bn | 993.80 Mn |
| 4 | Regeneron Pharmaceuticals | 82.05 Bn | 74.06 Bn | 3.93 Bn | 1.63 Bn |
| 5 | Moderna | 69.00 Bn | 63.87 Bn | 52.00 Mn | 651.00 Mn |
| 6 | Argenx Se | 61.15 Bn | 55.97 Bn | 1.37 Bn | -486.00 Mn |
| 7 | Alnylam Pharmaceuticals | 32.67 Bn | 29.37 Bn | 992.69 Mn | 413.13 Mn |
| 8 | Biogen | 32.37 Bn | 31.08 Bn | 1.96 Bn | 529.60 Mn |
| 9 | Roivant Sciences | 28.18 Bn | 28.87 Bn | 1.16 Mn | 202.02 Mn |
| 10 | Praxis Precision Medicines | 8.34 Bn | 7.58 Bn | - | 69.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69.42 Mn |
| Mar 31, 2026 | 77.99 Mn |
| Dec 31, 2025 | 77.51 Mn |
| Sep 30, 2025 | 65.80 Mn |
| Jun 30, 2025 | 63.01 Mn |
| Mar 31, 2025 | 60.81 Mn |
| Dec 31, 2024 | 56.29 Mn |
| Sep 30, 2024 | 41.88 Mn |
| Jun 30, 2024 | 27.26 Mn |
| Mar 31, 2024 | 26.98 Mn |
| Dec 31, 2023 | 18.39 Mn |
| Sep 30, 2023 | 17.26 Mn |
| Jun 30, 2023 | 25.61 Mn |
| Mar 31, 2023 | 25.50 Mn |
| Dec 31, 2022 | 28.33 Mn |
| Sep 30, 2022 | 30.44 Mn |
| Jun 30, 2022 | 43.62 Mn |
| Mar 31, 2022 | 52.65 Mn |
| Dec 31, 2021 | 43.51 Mn |
| Sep 30, 2021 | 33.14 Mn |
API Access
Praxis Precision Medicines Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=PRAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "PRAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=PRAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();